Viral Vectors and Plasmid DNA Global Market Report 2022: Market Size, Trends And Forecast To 2026

The Business Research Company's Viral Vectors and Plasmid DNA Global Market Report 2022: Market Size, Trends And Forecast To 2026

LONDON, GREATER LONDON, UK, October 18, 2022 / / -- According to 'Viral Vectors and Plasmid DNA Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026' published by The Business Research Company, the viral vectors and plasmid DNA market size is expected to grow from $0.69 billion in 2021 to $0.80 billion in 2022 at a compound annual growth rate (CAGR) of 14.80%. The growth in the market is mainly due to the outbreak of COVID-19 and requires targeted delivery of the drug to treat affected patients. The number of cases has been increasing resulting in a surge in demand for viral vectors & plasmid DNA. The viral vectors and plasmid DNA market is expected to reach $1.38 billion in 2026 at a CAGR of 14.80%. The rise in the global incidence of cancer is driving the viral vector & plasmid DNA market growth.

Want to learn more on the viral vectors and plasmid dna market growth? Request for a Sample now.

The viral vectors & plasmid DNA market consists of sales of viral vectors and plasmid DNA and related services. The viral vectors & plasmid DNA are used for the delivery of cellular therapies, like gene therapy and immunotherapy, and also for treating some viral infections. The viral vectors & plasmid DNA are used for formulation development in research and development labs. The viral vectors are genetically engineered viruses carrying viral RNA or DNA that is non-infectious but still contain viral promoters and transgene. The plasmid DNA is a double-stranded extrachromosomal and circular DNA sequence that is capable of replication using the host cell's replication system.

The major causes for most cancers include obesity, smoking, alcohol, improper eating habits. According to American cancer society 2020, an estimated 1.8 million new cancer cases diagnosed and 606,520 cancer deaths in the United States. The Cancer Research UK predicts that there will be 27.5 million new cases of cancer each year by 2040. The rise in the global incidence of cancer is expected to boost the demand for the viral vectors and plasmid DNA market over coming years.

The global viral vectors and plasmid dna market segmentation is as follows:
By Product: Plasmid DNA, Viral Vectors
By Application: Gene and Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Others
By Disease: Infectious Diseases, Genetic Disorders, Cancer, Others
By End-User: Research Institutes, Biopharmaceutical and Pharmaceutical Companies
By Geography: The global viral vectors and plasmid dna market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America accounts for the largest share.

Read more on the global viral vectors and plasmid dna market report here

Viral Vectors and Plasmid DNA Global Market Report 2022 is one of a series of new reports from The Business Research Company that provides viral vectors and plasmid dna market overviews, analyzes and forecasts market size and growth for the global viral vectors and plasmid dna market, viral vectors and plasmid dna global market share, viral vectors and plasmid dna global market segments and geographies, viral vectors and plasmid dna global market players, viral vectors and plasmid dna market leading competitor revenues, profiles and market shares. The viral vectors and plasmid dna market report identifies top countries and segments for opportunities and strategies based on market trends and key competitors' approaches.

TBRC's Viral Vectors and Plasmid DNA Global Market Report 2022 includes information on the following:

Data Segmentations: Market Size, Global, By Region and Country, Historic and Forecast, and Growth Rates for 60 Geographies

Key Market Players: FUJIFILM Diosynth Biotechnologies, FinVector Vision Therapies, Lonza, Cobra Biologics and Pharmaceutical Services, Brammer Bio.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

And so much more.

Looking for something else? Here is a list of similar reports by The Business Research Company:
Gene Therapy Global Market Report 2022

Antivirals Global Market Report 2022

Cellular Immunotherapy Global Market Report 2022

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email:

Check out our:
TBRC Blog:
LinkedIn:
Twitter:
Facebook:
YouTube:
Global Market Model:
Healthcare Blog:

Oliver Guirdham
The Business Research Company


Visit us on social media:

MENAFN18102022003118003196ID1105040517